These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 10732866)
1. Flow cytometry of p53 protein expression in some hematological malignancies. Koníková E; Kusenda J; Babusíková O Neoplasma; 1999; 46(6):368-76. PubMed ID: 10732866 [TBL] [Abstract][Full Text] [Related]
2. P53 protein expression in human leukemia and lymphoma cells. Koníková E; Kusenda J Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681 [TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients. Klobusická M; Kusenda J; Babusíková O Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373 [TBL] [Abstract][Full Text] [Related]
5. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
6. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients. Klobusická M; Kusenda J; Babusíková O Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099 [TBL] [Abstract][Full Text] [Related]
9. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia. Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study. Klobusická M; Kusenda J; Babusíkova O Neoplasma; 2001; 48(6):489-95. PubMed ID: 11949843 [TBL] [Abstract][Full Text] [Related]
11. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776 [TBL] [Abstract][Full Text] [Related]
13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of p53 and MDM2 proteins in hematological malignancies. Koníková E; Kusenda J Neoplasma; 2003; 50(1):31-40. PubMed ID: 12687276 [TBL] [Abstract][Full Text] [Related]
15. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells. Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006 [TBL] [Abstract][Full Text] [Related]
16. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma. Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. Babuŝíková O; Tomová A; Kusenda J; Gyárfás J Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978 [TBL] [Abstract][Full Text] [Related]
19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy? Aswald JM; Wang XH; Aswald S; Lutynski A; Minden MD; Messner HA; Keating A Cytometry B Clin Cytom; 2006 Nov; 70(6):379-90. PubMed ID: 16977635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]